COVID-19 Resource Centre » Response Webinar Series »

Presented on April 20, 2020 by Dr. Roberto Caporali

During this 1-hour webinar, Dr. Caporali will share his experiences with Canadian rheumatologists; he will discuss how the management of rheumatic patients has been impacted by the COVID-19 pandemic and the relevancy of anti-rheumatic drugs as possible therapies for the coronavirus disease.

Learning Objectives
At the end of this session, participants will be able to:

1. discuss best practices for the management of rheumatic patients during the COVID-19 pandemic
2. describe anti-rheumatic drugs as possible therapies for COVID-19
3. recognize COVID-19, cytokines and severe acute respiratory syndrome

CanMEDS Roles

1. Medical Expert
2. Collaborator
3. Scholar

This webinar is part of a series supported by unrestricted educational grants from CRA COVID-19 Response Webinar Series supporters.